
UnitedHealth Group, Eli Lilly and Company, Medline, Moderna, Humana, Thermo Fisher Scientific, and CVS Health are the seven Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of publicly traded companies that provide healthcare-related products or services, such as pharmaceuticals, medical devices, hospitals, and health insurance. For investors, they offer exposure to the healthcare sector, whose performance can be influenced by medical innovation, regulation, demographics, and demand for care. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of NYSE UNH traded down $34.28 during mid-day trading on Wednesday, reaching $355.40. 6,876,998 shares of the company were exchanged, compared to its average volume of 7,158,674. The stock has a market capitalization of $318.45 billion, a P/E ratio of 20.33, a P/E/G ratio of 1.49 and a beta of 0.51. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company’s 50-day simple moving average is $391.42 and its 200-day simple moving average is $366.73. UnitedHealth Group has a twelve month low of $255.96 and a twelve month high of $461.62.
Read Our Latest Research Report on UNH
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
LLY traded down $23.32 on Wednesday, reaching $1,392.23. The company had a trading volume of 1,135,270 shares, compared to its average volume of 2,948,886. The stock has a market cap of $1.31 trillion, a P/E ratio of 45.21, a P/E/G ratio of 1.71 and a beta of 0.40. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.00 and a current ratio of 1.39. Eli Lilly and Company has a fifty-two week low of $850.51 and a fifty-two week high of $1,475.25. The company’s fifty day moving average is $1,253.71 and its 200 day moving average is $1,114.28.
Read Our Latest Research Report on LLY
Medline (MDLN)
Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities.
MDLN stock traded up $1.61 during mid-day trading on Wednesday, hitting $39.29. 26,867,035 shares of the company were exchanged, compared to its average volume of 7,883,077. Medline has a 1-year low of $31.37 and a 1-year high of $50.88. The stock has a market capitalization of $51.68 billion and a PE ratio of 89.22. The business has a 50 day simple moving average of $35.39 and a 200-day simple moving average of $39.31. The company has a current ratio of 4.04, a quick ratio of 2.51 and a debt-to-equity ratio of 0.65.
Read Our Latest Research Report on MDLN
Moderna (MRNA)
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.
Shares of Moderna stock traded down $5.05 on Wednesday, hitting $201.75. The stock had a trading volume of 3,412,975 shares, compared to its average volume of 12,487,329. The stock has a market cap of $81.63 billion, a price-to-earnings ratio of -28.54 and a beta of 1.16. The company has a quick ratio of 3.47, a current ratio of 3.62 and a debt-to-equity ratio of 0.52. Moderna has a twelve month low of $22.28 and a twelve month high of $280.80. The business’s 50 day moving average is $204.39 and its two-hundred day moving average is $98.06.
Read Our Latest Research Report on MRNA
Humana (HUM)
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
NYSE:HUM traded down $45.96 during mid-day trading on Wednesday, hitting $397.38. 1,519,769 shares of the stock were exchanged, compared to its average volume of 1,650,447. The firm’s 50-day simple moving average is $410.55 and its 200 day simple moving average is $319.48. The stock has a market capitalization of $47.72 billion, a price-to-earnings ratio of 38.78, a price-to-earnings-growth ratio of 2.20 and a beta of 0.65. Humana has a fifty-two week low of $163.11 and a fifty-two week high of $462.87. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.65 and a current ratio of 1.65.
Read Our Latest Research Report on HUM
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
TMO stock traded up $6.39 during trading hours on Wednesday, hitting $693.18. 825,244 shares of the stock were exchanged, compared to its average volume of 2,241,695. The company has a current ratio of 1.81, a quick ratio of 1.41 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $256.84 billion, a P/E ratio of 36.54, a P/E/G ratio of 2.82 and a beta of 0.84. The company has a 50-day simple moving average of $674.07 and a two-hundred day simple moving average of $557.70. Thermo Fisher Scientific has a 12 month low of $435.27 and a 12 month high of $727.56.
Read Our Latest Research Report on TMO
CVS Health (CVS)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Shares of CVS Health stock traded down $2.95 during trading on Wednesday, reaching $82.86. The company’s stock had a trading volume of 6,902,122 shares, compared to its average volume of 8,646,321. The business’s 50-day moving average price is $89.28 and its 200-day moving average price is $89.22. The firm has a market cap of $106.02 billion, a PE ratio of 9.66, a P/E/G ratio of 0.77 and a beta of 0.58. CVS Health has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.
Read Our Latest Research Report on CVS
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in November 2026
- Palantir’s Political Controversy Is Hiding a Much Bigger Story
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
